Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Spotlight on Amylin Combination Strategy 22.5% Weight Loss Achieved in Phase 2 Trial "Amylin Combination Therapy to Address Nausea Side Effects Draws Attention" With Roche making a full-fledged entry into the global obesity drug market, which has been dominated by Eli Lilly and Novo Nordisk, signs are emerging of a major shift in the competitive landscape for obesity treatments
NHS to offer new weight loss jab tirzepatide on the NHS
Despite the consistency of MACE reduction across several agents, different trial designs, population, and exposure, argues for a true class effect, yet several critical issues remain unresolved
For people who prefer morning injection and want to minimize the intensity of the initial side effect wave, thigh injection may offer a marginal advantage
GLP-1 Pipeline Update: August 2025 Quarterly view of the GLP-1 pipeline and anticipated indications Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Associate Vice President, Clinical Information Carole Kerzic, RPh Executive Editor Drug Information Pharmacist Principal Nicole Kjesbo, PharmD, BCPS Executive Editor Clinical Program Development Director Senior, Pipeline DISCLAIMER The drug pipeline is fluid
